NCT06150183
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06150183
Title Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioNTech SE
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | ESP | DNK | BEL

Facility Status City State Zip Country Details
START Midwest Grand Rapids Michigan 49546 United States Details
Carolina BioOncology Institute, LLC Huntersville North Carolina 28078 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
GZA Ziekenhuizen Antwerp 2018 Belgium Details
CHU de Liège Liège 4000 Belgium Details
Rigshospitalet Copenhagen DK-2100 Denmark Details
National Cancer Center Hospital East Kashiwanoha 277-8577 Japan Details
Hospital Quironsalud Barcelona (NEXT Barcelona) Barcelona 08023 Spain Details
Hospital Fund. Jiménez Dia Madrid 28040 Spain Details
Hospital HM Univ. Sanchinarro, Ensayos START Madrid 28050 Spain Details
Clinica Universidad de Navarra Pamplona 31008 Spain Details
Royal Marsden Hospital - London London SW36JJ United Kingdom Details
The Christie Hospital Manchester M20 4BX United Kingdom Details
Northern Centre for Cancer Care Newcastle NE7 7DN United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field